Brian N. Swanson

8.0k total citations · 4 hit papers
64 papers, 3.4k citations indexed

About

Brian N. Swanson is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Brian N. Swanson has authored 64 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 12 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Brian N. Swanson's work include Asthma and respiratory diseases (16 papers), IL-33, ST2, and ILC Pathways (9 papers) and Analytical Methods in Pharmaceuticals (8 papers). Brian N. Swanson is often cited by papers focused on Asthma and respiratory diseases (16 papers), IL-33, ST2, and ILC Pathways (9 papers) and Analytical Methods in Pharmaceuticals (8 papers). Brian N. Swanson collaborates with scholars based in United States, France and Belgium. Brian N. Swanson's co-authors include David Floyd, Suzanne Moreland, Karnail S. Atwal, Brian C. O'Reilly, Anders Hedberg, Jennifer D. Hamilton, Neil M.H. Graham, Gianluca Pirozzi, Peter H. Vlasses and George D. Yancopoulos and has published in prestigious journals such as JAMA, American Journal of Respiratory and Critical Care Medicine and Analytical Biochemistry.

In The Last Decade

Brian N. Swanson

63 papers receiving 3.3k citations

Hit Papers

Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoy... 1990 2026 2002 2014 1991 2016 2018 1990 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents
    1991 721 citations Karnail S. Atwal, Brian N. Swanson et al. Journal of Medicinal Chemistry profile →
  2. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
    2016 553 citations Claus Bachert, Leda Mannent et al. profile →
  3. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    2018 477 citations Emma Guttman‐Yassky, Robert Bissonnette et al. Journal of Allergy and Clinical Immunology profile →
  4. Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines
    1990 342 citations Karnail S. Atwal, George C. Rovnyak et al. Journal of Medicinal Chemistry profile →

Peers

Brian N. Swanson
Yoshimasa Inoue Japan
Louise M. Dubé United States
Garrett Fitzgerald United States
Peter T. Daley‐Yates United Kingdom
Douglas R. Morton United States
James H. Williams United States
George C. Roush United States
Mokenge P. Malafa United States
Daniel W. Nixon United States
Carol J. Fabian United States
Yoshimasa Inoue Japan
Brian N. Swanson
Citations per year, relative to Brian N. Swanson Brian N. Swanson (= 1×) peers Yoshimasa Inoue

Countries citing papers authored by Brian N. Swanson

Since Specialization
Citations

This map shows the geographic impact of Brian N. Swanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian N. Swanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian N. Swanson more than expected).

Fields of papers citing papers by Brian N. Swanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian N. Swanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian N. Swanson. The network helps show where Brian N. Swanson may publish in the future.

Co-authorship network of co-authors of Brian N. Swanson

This figure shows the co-authorship network connecting the top 25 collaborators of Brian N. Swanson. A scholar is included among the top collaborators of Brian N. Swanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian N. Swanson. Brian N. Swanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marlowe, Elizabeth M., Brian N. Swanson, Susan Realegeno, et al.. (2025). Epidemiological Burden of Hepatitis Delta Virus in the United States. Journal of Viral Hepatitis. 32(6). e70029–e70029.
2.
Bachert, Claus, Tanya M. Laidlaw, Seong Cho, et al.. (2023). Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. Annals of Otology Rhinology & Laryngology. 132(12). 1649–1661. 16 indexed citations
3.
Bachert, Claus, Seong Cho, Tanya M. Laidlaw, et al.. (2020). Dupilumab Reduces Blood, Urine, and Nasal Biomarkers of Type 2 Inflammation in Patients With Chronic Rhinosinusitis With Nasal Polyps in the Phase 3 SINUS-52 Trial. Journal of Allergy and Clinical Immunology. 145(2). AB185–AB185. 5 indexed citations
4.
Wenzel, Sally E., Ian Pavord, Jaman Maroni, et al.. (2018). Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST. American Journal of Respiratory and Critical Care Medicine. 197. 12 indexed citations
5.
Davis, John D., Ashish Bansal, David Hassman, et al.. (2018). Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab. Clinical Pharmacology & Therapeutics. 104(6). 1146–1154. 34 indexed citations
6.
Nelson, Hal T., Brian N. Swanson, & Nicholas Cain. (2017). Close and Connected: The Effects of Proximity and Social Ties on Citizen Opposition to Electricity Transmission Lines. Environment and Behavior. 50(5). 567–596. 16 indexed citations
7.
Guttman‐Yassky, Emma, Jennifer D. Hamilton, Robert Bissonnette, et al.. (2016). 373 Dupilumab improves clinical atopic dermatitis parameters and modulates specific IgEs and Staphylococcus aureus abundance. Journal of Investigative Dermatology. 136(9). S224–S224. 3 indexed citations
8.
Hamilton, Jennifer D., Sara Hamon, Eric L. Simpson, et al.. (2016). 372 The effect of dupilumab on biomarkers in a randomized phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis. Journal of Investigative Dermatology. 136(9). S224–S224. 6 indexed citations
9.
IsHak, Waguih William, et al.. (2011). The Impact of Psychotherapy, Pharmacotherapy, and Their Combination on Quality of Life in Depression. Harvard Review of Psychiatry. 19(6). 277–289. 40 indexed citations
10.
Liao, Wei‐Chi, O. Vesterqvist, Carol Delaney, et al.. (2003). Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects. British Journal of Clinical Pharmacology. 56(4). 395–406. 18 indexed citations
11.
Vesterqvist, O., et al.. (1998). Determination of metformin in plasma by high-performance liquid chromatography after ultrafiltration. Journal of Chromatography B Biomedical Sciences and Applications. 716(1-2). 299–304. 64 indexed citations
12.
13.
Atwal, Karnail S., Brian N. Swanson, David Floyd, et al.. (1991). Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents. Journal of Medicinal Chemistry. 34(2). 806–811. 721 indexed citations breakdown →
14.
Atwal, Karnail S., George C. Rovnyak, S. David Kimball, et al.. (1990). Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines. Journal of Medicinal Chemistry. 33(9). 2629–2635. 342 indexed citations breakdown →
15.
Vlasses, Peter H., Heschi H. Rotmensch, Brian N. Swanson, Regina Clementi, & R Ferguson. (1989). Effect of repeated doses of L-5-hydroxytryptophan and carbidopa on prolactin and aldosterone secretion in man. Journal of Endocrinological Investigation. 12(2). 87–91. 2 indexed citations
16.
Fruncillo, Richard J., et al.. (1986). Effect of Renal Failure or Biliary Stasis on the Pharmacokinetics of Amiodarone in the Rat. Journal of Pharmaceutical Sciences. 75(2). 150–154. 9 indexed citations
17.
Vlasses, Peter H., et al.. (1983). Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in Combination. The Journal of Clinical Pharmacology. 23(5-6). 227–233. 27 indexed citations
18.
Swanson, Brian N., et al.. (1983). Peripheral Neuropathy After Concomitant Administration of Dimethyl Sulfoxide and Sulindac. Arthritis & Rheumatism. 26(6). 791–793. 3 indexed citations
19.
Swanson, Brian N., et al.. (1982). Sulindac disposition when given once and twice daily. Clinical Pharmacology & Therapeutics. 32(3). 397–403. 28 indexed citations
20.
Vlasses, Peter H., R Ferguson, John D. Irvin, et al.. (1982). Synergistic antihypertensive effect of MK-421 and hydrochlorothiazide. The American Journal of Cardiology. 49(4). 923–923. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshimasa Inoue Breakdown of academic impact, for papers by Louise M. Dubé Breakdown of academic impact, for papers by Garrett Fitzgerald Breakdown of academic impact, for papers by Peter T. Daley‐Yates Breakdown of academic impact, for papers by Douglas R. Morton Breakdown of academic impact, for papers by James H. Williams Breakdown of academic impact, for papers by George C. Roush Breakdown of academic impact, for papers by Mokenge P. Malafa Breakdown of academic impact, for papers by Daniel W. Nixon Breakdown of academic impact, for papers by Carol J. Fabian
Rankless by CCL
2026